Safety and pharmacokinetics of subcutaneous administration of broadly neutralizing antiHIV1 monoclonal antibodies bNAbs given to HIV1 exposed uninfected neonates and infants study protocol for a phase I trial
dc.article.end-page | 17 | en |
dc.article.start-page | 1 | en |
dc.citation.doi | 10.1186/S12879-024-09588-3 | en |
dc.contributor.author | A Goga | en |
dc.contributor.author | Trisha Ramraj | en |
dc.contributor.author | Logashvari Naidoo | en |
dc.contributor.author | Brodie Daniels | en |
dc.contributor.author | Penelope Moore | en |
dc.contributor.author | Nonhlanhla Mkhize | en |
dc.contributor.author | E et al | en |
dc.date.accessioned | 2025-01-22T11:52:40Z | |
dc.date.available | 2025-01-22T11:52:40Z | |
dc.faculty | FACULTY OF HEALTH SCIENCES | en |
dc.identifier.citation | WOS | en |
dc.identifier.issn | 1471-2334 | en |
dc.identifier.uri | https://hdl.handle.net/10539/43619 | |
dc.journal.title | Safety and pharmacokinetics of subcutaneous administration of broadly neutralizing antiHIV1 monoclonal antibodies bNAbs given to HIV1 exposed uninfected neonates and infants study protocol for a phase I trial | en |
dc.journal.volume | 24 | en |
dc.publisher | BIOMED CENTRAL LTD | en |
dc.title | Safety and pharmacokinetics of subcutaneous administration of broadly neutralizing antiHIV1 monoclonal antibodies bNAbs given to HIV1 exposed uninfected neonates and infants study protocol for a phase I trial | en |
dc.type | Journal Article | en |
Files
Original bundle
1 - 1 of 1
- Name:
- Journal Article.pdf
- Size:
- 1.28 MB
- Format:
- Adobe Portable Document Format
- Description:
- Bitstream uploaded by REST Client